Medi-Weightloss vs NovoCare Pharmacy
NovoCare Pharmacy costs $50 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
NovoCare Pharmacy
Best for: an oral route if you will not self-inject
Visit NovoCare Pharmacy →If you are choosing between Medi-Weightloss and NovoCare Pharmacy, the first difference is cost: NovoCare Pharmacy is $50 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. NovoCare Pharmacy leads our six-part score, 7.9 to 5.5.
Medi-Weightloss vs NovoCare Pharmacy price
NovoCare Pharmacy is the cheaper way in: $149 a month against $199 a month at Medi-Weightloss. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at NovoCare Pharmacy ($149 a month vs $199 a month).
Medications and formats
Both sell semaglutide.
On format they match: each offers brand-name pens.
Where each one treats patients
Medi-Weightloss does not publish where it ships, and NovoCare Pharmacy lists 50 states.
Pricing
Medi-Weightloss
NovoCare Pharmacy
Self-pay; one month is one bottle of 30 tablets
Self-pay; one month is one bottle of 30 tablets
Self-pay; one month is one bottle of 30 tablets
$199/mo intro = first 2 monthly fills (0.25/0.5 mg) for patients new to the offer/pharmacy, through 6/30/2026; then $349/mo standard
with commercial insurance, as little as $25/mo; subject to max savings of $100/month
What each price covers
Neither Medi-Weightloss nor NovoCare Pharmacy spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.
Where each one scores higher
Overall, NovoCare Pharmacy scores 7.9 and Medi-Weightloss 5.5 out of 10.
NovoCare Pharmacy is stronger on value (10.0 vs 5.0), user experience (5.0 vs 2.5), trust & safety (6.0 vs 4.0) and accessibility (10.0 vs 5.0).
Effectiveness and support are within half a point.
Medi-Weightloss
5.5/10
NovoCare Pharmacy
7.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Medi-Weightloss nor NovoCare Pharmacy has an FDA warning letter on record with us.
Features & Coverage
| Feature | Medi-Weightloss | NovoCare Pharmacy |
|---|---|---|
| Starting Price | $199/mo | ✓$149/mo |
| Features | ✓8 features | 5 features |
| States Available | Not disclosed | 50 |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | ✓ Yes | — |
| FDA Warning Letters | None | None |
About Medi-Weightloss
A new-patient visit at Medi-Weightloss runs about $199 and covers a medical assessment, labs and a GLP-1 eligibility review; what medication costs after that depends on the plan. The physician-supervised brand has 130-plus locations nationwide alongside telehealth, and prescribes branded Wegovy and Zepbound, compounded semaglutide and compounded tirzepatide, plus older agents such as phentermine. Programs are evidence-based and include body-composition analysis and personalized plans. Insurance is accepted at many locations, and HSA/FSA funds are welcome.
Read our full Medi-Weightloss review →About NovoCare Pharmacy
NovoCare Pharmacy is Novo Nordisk's own first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide), a manufacturer-owned channel. Wegovy 0.25 mg and 0.5 mg starter doses run $199/month through 6/30/2026; full-dose Wegovy is $349/month at standard self-pay, and Wegovy HD is $399/month. It ships nationwide. Telehealth platforms that route Wegovy through NovoCare are a separate thing from the manufacturer pharmacy itself.
Read our full NovoCare Pharmacy review →Pros & Cons
Medi-Weightloss
What we like
- Semaglutide costs $199 a month, 80% below the $990 median for brand-name semaglutide across the sellers we compare
- The monthly price stays the same as your dose goes up
- We found no FDA warning letters issued to Medi-Weightloss
- Baseline bloodwork is required before a prescription
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
NovoCare Pharmacy
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to NovoCare Pharmacy
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
NovoCare Pharmacy wins this one, 7.9 to 5.5, above all for an oral route if you will not self-inject. It also costs $50 less each month than Medi-Weightloss. Medi-Weightloss fits better if semaglutide from $199/month is your priority.
Choose Medi-Weightloss if…
You want semaglutide from $199/month and an opening price near $199 a month.
Choose NovoCare Pharmacy if…
You want an oral route if you will not self-inject and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Medi-Weightloss vs NovoCare Pharmacy: FAQ
Close alternatives to Medi-Weightloss and NovoCare Pharmacy
- Medi-Weightloss vs Superpower
- Medi-Weightloss vs Eclipse Medical Wellness
- Medi-Weightloss vs Walgreens Weight Management
- NovoCare Pharmacy vs Walgreens Weight Management
- NovoCare Pharmacy vs Eclipse Medical Wellness
- NovoCare Pharmacy vs Superpower
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.